Considering the frequent occurrence of FGFR3 aberrations in HPV‐positive HNSCC and impressive response to FGFR‐inhibitors, FGFR3 protein might be of therapeutic value in this HNSCC subpopulation. The gene discussed is FGFR3; the disease is head and neck squamous cell carcinoma.